THALOMID Side Effects

7023283-0 | Spinal Cord Compression
on Sep 21, 2010 Male patient from UNITED STATES , 60 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: spinal cord compression. Thalomid dosage: . During the same period patient was treated with DECADRON (View Decadron Review and Decadron Label ).

7015790-1 | Pneumonia Aspiration, Toxic Encephalopathy
Patient was taking Thalomid (View Usage). Patient had the following side effects: pneumonia aspiration, toxic encephalopathy on Sep 21, 2010 from UNITED STATES Additional patient health information: Male patient , 66 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Thalomid dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), BORTEZOMIB (View Bortezomib Review and Bortezomib Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ). Patient was hospitalized.

7009890-X | Hypocalcaemia, Leukocytoclastic Vasculitis, Renal Failure
Adverse event was reported on Sep 14, 2010 by a Female patient taking Thalomid (View Usage) (Dosage: ) . Location: UNITED STATES , 85 years of age, weighting 206.8 lb, After Thalomid was administered, patient had the following side effects: hypocalcaemia, leukocytoclastic vasculitis, renal failure. During the same period patient was treated with MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), CHLORTHALIDONE (View Chlorthalidone Review and Chlorthalidone Label ), MOXIFLOXACIN (View Moxifloxacin Review and Moxifloxacin Label ), ZOMETA (View Zometa Review and Zometa Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

7000870-7 | Anaemia, Bacteraemia, Pneumonia Aspiration
on Sep 07, 2010 Male patient from CANADA , weighting 122.6 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), atrial fibrillation (What is atrial fibrillation?) and was treated with Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, bacteraemia, pneumonia aspiration. Thalomid dosage: . During the same period patient was treated with MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.


6991637-4 | Fall
on Sep 02, 2010 Female patient from CANADA , weighting 181.9 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). Patient had the following side effects: fall (What is fall?). Thalomid dosage: . During the same period patient was treated with MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6987448-6 | Lung Disorder, Multi-organ Failure, Sepsis
Patient was taking Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: lung disorder, multi-organ failure, sepsis (What is sepsis?) on Sep 10, 2010 from UNITED STATES Additional patient health information: Female patient , 16 years of age, . Thalomid dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6963741-8 | Atrial Flutter, Renal Failure, Sepsis
Adverse event was reported on Aug 25, 2010 by a Female patient taking Thalomid (View Usage) (Dosage: ) . Location: UNITED STATES , 76 years of age, weighting 146.6 lb, Patient experienced the following unwanted or unexpected effects: atrial flutter, renal failure, sepsis (What is sepsis?). During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ZOMETA (View Zometa Review and Zometa Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6956965-7 | Malignant Neoplasm Progression, Thrombocytopenia
on Aug 27, 2010 Male patient from UNITED STATES , 82 years of age, was treated with Thalomid (View Usage). Patient had the following side effects: malignant neoplasm progression, thrombocytopenia. Thalomid dosage: . Patient was hospitalized.

6954958-7 | Cardiac Failure, Multi-organ Failure, Septic Shock, Weight Decreased
on Aug 18, 2010 Male patient from JAPAN , 69 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: cardiac failure, multi-organ failure, septic shock, weight decreased. Thalomid dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6914026-7 | Blood Human Chorionic Gonadotropin Abnormal, Blood Human Chorionic Gonadotropin Increased
Patient was taking Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: blood human chorionic gonadotropin abnormal, blood human chorionic gonadotropin increased on Jul 28, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 160.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Thalomid dosage: . During the same period patient was treated with VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), IRON (View Iron Review and Iron Label ).

6867395-0 | Nodal Arrhythmia
Adverse event was reported on Jun 02, 2009 by a Male patient taking Thalomid (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?), anaemia and. Location: AUSTRALIA , weighting 127.9 lb, Patient had the following side effects: nodal arrhythmia. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6844789-0 | Bone Marrow Failure, Cellulitis
on Jul 02, 2010 Male patient from UNITED STATES , weighting 74.96 lb, was diagnosed with prophylaxis and was treated with Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: bone marrow failure, cellulitis (What is cellulitis?). Thalomid dosage: . During the same period patient was treated with CYTOXAN (View Cytoxan Review and Cytoxan Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CELEBREX (View Celebrex Review and Celebrex Label ), VALACYCLOVIR (View Valacyclovir Review and Valacyclovir Label ), MICONAZOLE (View Miconazole Review and Miconazole Label ), PEPCID (View Pepcid Review and Pepcid Label ). Patient was hospitalized.

6843577-9 | Hypocalcaemia, Leukocytoclastic Vasculitis, Renal Failure
on Jul 03, 2010 Female patient from UNITED STATES , 85 years of age, weighting 206.8 lb, was treated with Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: hypocalcaemia, leukocytoclastic vasculitis, renal failure. Thalomid dosage: . During the same period patient was treated with MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), CHLORTHALIDONE (View Chlorthalidone Review and Chlorthalidone Label ), MOXIFLOXACIN (View Moxifloxacin Review and Moxifloxacin Label ), ZOMETA (View Zometa Review and Zometa Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

6840165-5 | Cardiac Disorder, Gastrointestinal Disorder, Infection, Neuropathy Peripheral, Neutropenia, Thrombocytopenia
Patient was taking Thalomid (View Usage). Patient had the following side effects: cardiac disorder, gastrointestinal disorder, infection (What is infection?), neuropathy peripheral, neutropenia, thrombocytopenia on Jul 02, 2010 from ITALY Additional patient health information: Female patient , 71 years of age, . Thalomid dosage: . During the same period patient was treated with BORTEZOMIB (View Bortezomib Review and Bortezomib Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6836496-5 | Blood Human Chorionic Gonadotropin Abnormal, Blood Human Chorionic Gonadotropin Increased
Adverse event was reported on Jun 30, 2010 by a Female patient taking Thalomid (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , weighting 160.1 lb, After Thalomid was administered, patient had the following side effects: blood human chorionic gonadotropin abnormal, blood human chorionic gonadotropin increased. During the same period patient was treated with VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), IRON (View Iron Review and Iron Label ).

6796147-5 | Bone Marrow Failure, Cellulitis
on Jun 16, 2010 Male patient from UNITED STATES , weighting 74.96 lb, was diagnosed with prophylaxis and was treated with Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, cellulitis (What is cellulitis?). Thalomid dosage: . During the same period patient was treated with CYTOXAN (View Cytoxan Review and Cytoxan Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CELEBREX (View Celebrex Review and Celebrex Label ), VALACYCLOVIR (View Valacyclovir Review and Valacyclovir Label ), MICONAZOLE (View Miconazole Review and Miconazole Label ), PEPCID (View Pepcid Review and Pepcid Label ). Patient was hospitalized.

6786849-9 | Asthenia, Atrial Fibrillation, Bradycardia, Cardiac Failure Congestive, Coronary Artery Disease, Fluid Retention, Haematocrit Decreased, Haematuria, International Normalised Ratio Decreased
on Jun 18, 2010 Male patient from UNITED STATES , weighting 163.8 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). Patient had the following side effects: asthenia, atrial fibrillation (What is atrial fibrillation?), bradycardia, cardiac failure congestive, coronary artery disease (What is coronary artery disease?), fluid retention, haematocrit decreased, haematuria, international normalised ratio decreased. Thalomid dosage: . During the same period patient was treated with DEXAMETHASONE ACETATE (View Dexamethasone Acetate Review and Dexamethasone Acetate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), COUMADIN (2.5-7.5mg) (View Coumadin Review and Coumadin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6784887-3 | Asthenia, Confusional State, Fall, Idiopathic Thrombocytopenic Purpura, Multiple Myeloma, Neutropenia
Patient was taking Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: asthenia, confusional state, fall (What is fall?), idiopathic thrombocytopenic purpura, multiple myeloma (What is multiple myeloma?), neutropenia on Jun 17, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 185.2 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Thalomid dosage: . During the same period patient was treated with DEXAMETHASONE ACETATE (View Dexamethasone Acetate Review and Dexamethasone Acetate Label ), HCTZ (View Hctz Review and Hctz Label ), REMERON (View Remeron Review and Remeron Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), SENNA (View Senna Review and Senna Label ), ZOMETA (View Zometa Review and Zometa Label ).

6780747-2 | Pneumonia, Pyothorax
Adverse event was reported on Jun 15, 2010 by a Male patient taking Thalomid (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , weighting 119.9 lb, Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?), pyothorax. During the same period patient was treated with NORCO 7.5 (View Norco 7.5 Review and Norco 7.5 Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized and became disabled.

6775514-X | Constipation, Diverticulitis, Hypertension, Neuropathy Peripheral, Pulmonary Embolism
on Jun 08, 2010 Female patient from UNITED STATES , 81 years of age, weighting 112.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). Patient had the following side effects: constipation (What is constipation?), diverticulitis, hypertension, neuropathy peripheral, pulmonary embolism (What is pulmonary embolism?). Thalomid dosage: . During the same period patient was treated with DECADRON (View Decadron Review and Decadron Label ), VELCADE (View Velcade Review and Velcade Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), MECLIZINE (View Meclizine Review and Meclizine Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ). Patient was hospitalized.

6770164-3 | Alcohol Poisoning
on Jun 09, 2010 Female patient from UNITED STATES , weighting 151.1 lb, was treated with Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: alcohol poisoning. Thalomid dosage: . During the same period patient was treated with ETHANOL (View Ethanol Review and Ethanol Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), TRAZODONE HYDROCHLORIDE (View Trazodone Hydrochloride Review and Trazodone Hydrochloride Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), CARISOPRODOL (View Carisoprodol Review and Carisoprodol Label ).

6770111-4 | Acute Respiratory Distress Syndrome
Patient was taking Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome on Jun 08, 2010 from UNITED STATES Additional patient health information: Male patient , 54 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Thalomid dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), BORTEZOMIB (View Bortezomib Review and Bortezomib Label ), ANTI THYMOCYTE GLOBULIN NOS (View Anti-thymocyte Globulin Nos Review and Anti-thymocyte Globulin Nos Label ).

6769145-5 | Complications Of Bone Marrow Transplant
Adverse event was reported on Jun 08, 2010 by a Female patient taking Thalomid (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , 56 years of age, Patient had the following side effects: complications of bone marrow transplant. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), FLUDARABINE (View Fludarabine Review and Fludarabine Label ), ANTI THYMOCYTE GLOBULIN NOS (View Anti-thymocyte Globulin Nos Review and Anti-thymocyte Globulin Nos Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ).

6768276-3 | Cough, Disease Progression, Fatigue, Mallory-weiss Syndrome, Pregnancy, Treatment Noncompliance, Vomiting
on Jun 07, 2010 Female patient from UNITED STATES , weighting 123.1 lb, was treated with Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: cough, disease progression, fatigue, mallory-weiss syndrome, pregnancy (What is pregnancy?), treatment noncompliance, vomiting. Thalomid dosage: . During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ).

6767296-2 | Atrial Fibrillation, Bronchopneumonia, Pericardial Effusion
on Jun 07, 2010 Female patient from UNITED STATES , weighting 160.1 lb, was diagnosed with myelofibrosis and was treated with Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), bronchopneumonia, pericardial effusion. Thalomid dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6758982-9 | Cardiac Amyloidosis, Dyspnoea, Hypotension, Nausea, Oedema Peripheral, Pleural Effusion
Patient was taking Thalomid (View Usage). Patient had the following side effects: cardiac amyloidosis, dyspnoea, hypotension, nausea (What is nausea?), oedema peripheral, pleural effusion on May 26, 2010 from UNITED STATES Additional patient health information: Female patient , 63 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Thalomid dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), BORTEZOMIB (View Bortezomib Review and Bortezomib Label ). Patient was hospitalized.

6754637-5 |
Adverse event was reported on May 29, 2010 by a Male patient taking Thalomid (View Usage) (Dosage: ) . Location: UNITED STATES , 70 years of age, weighting 164.2 lb, . During the same period patient was treated with MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6752434-8 | Cough, Disease Progression, Fatigue, Mallory-weiss Syndrome, Pregnancy, Treatment Noncompliance, Vomiting
on May 24, 2010 Female patient from UNITED STATES , weighting 123.1 lb, was treated with Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: cough, disease progression, fatigue, mallory-weiss syndrome, pregnancy (What is pregnancy?), treatment noncompliance, vomiting. Thalomid dosage: . During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ).

6751775-8 | Deep Vein Thrombosis, Neuropathy Peripheral, Osteomyelitis, Osteonecrosis, Paraesthesia, Protein Urine Present, Pulmonary Embolism
on May 21, 2010 Female patient from UNITED STATES , weighting 153.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), neuropathy peripheral, osteomyelitis, osteonecrosis (What is osteonecrosis?), paraesthesia, protein urine present, pulmonary embolism (What is pulmonary embolism?). Thalomid dosage: . During the same period patient was treated with AREDIA (View Aredia Review and Aredia Label ), VELCADE (View Velcade Review and Velcade Label ), DECADRON (View Decadron Review and Decadron Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ).

6738771-1 | Cough, Disease Progression, Fatigue, Mallory-weiss Syndrome, Pregnancy, Treatment Noncompliance, Vomiting
Patient was taking Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: cough, disease progression, fatigue, mallory-weiss syndrome, pregnancy (What is pregnancy?), treatment noncompliance, vomiting on May 14, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 123.1 lb, . Thalomid dosage: . During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ).

6725653-4 | Arthralgia, Balance Disorder, Dyspnoea, Fatigue, Hypoaesthesia, Joint Stiffness, Muscular Weakness, Musculoskeletal Stiffness, Pain In Extremity
Adverse event was reported on May 13, 2010 by a Female patient taking Thalomid (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , 81 years of age, weighting 173.0 lb, Patient experienced the following unwanted or unexpected effects: arthralgia, balance disorder, dyspnoea, fatigue, hypoaesthesia, joint stiffness, muscular weakness, musculoskeletal stiffness, pain in extremity.

6725070-7 | Constipation, Haemorrhoids
on May 04, 2010 Female patient from UNITED STATES , weighting 124.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). Patient had the following side effects: constipation (What is constipation?), haemorrhoids. Thalomid dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), NEXIUM (View Nexium Review and Nexium Label ), OSCAL (View Oscal Review and Oscal Label ), XANAX (View Xanax Review and Xanax Label ), ACTONEL (View Actonel Review and Actonel Label ), PREMARIN (View Premarin Review and Premarin Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ). Patient was hospitalized.

6723565-3 | Bradycardia, Failure To Thrive, Haemoglobin Decreased, Hypotension, Mass
on May 06, 2010 Male patient from UNITED STATES , 79 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: bradycardia, failure to thrive, haemoglobin decreased, hypotension, mass. Thalomid dosage: . Patient was hospitalized.

6721539-X | Ileus, Jaundice
Patient was taking Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: ileus, jaundice (What is jaundice?) on Apr 30, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 142.6 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Thalomid dosage: . During the same period patient was treated with PERCOCET (View Percocet Review and Percocet Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), COMPAZINE (View Compazine Review and Compazine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), BORTEZOMIB (View Bortezomib Review and Bortezomib Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), ZOLEDRONIC ACID (View Zoledronic Acid Review and Zoledronic Acid Label ), ERYTHROPOIETIC AGENT (View Erythropoietic Agent Review and Erythropoietic Agent Label ).

6720416-8 | Blood Human Chorionic Gonadotropin Abnormal, Blood Human Chorionic Gonadotropin Increased
Adverse event was reported on Apr 30, 2010 by a Female patient taking Thalomid (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , weighting 160.1 lb, Patient had the following side effects: blood human chorionic gonadotropin abnormal, blood human chorionic gonadotropin increased. During the same period patient was treated with VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), IRON (View Iron Review and Iron Label ).

6709021-7 | Pregnancy Of Partner
on Apr 22, 2010 Male patient from UNITED STATES , 37 years of age, was treated with Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: pregnancy of partner. Thalomid dosage: .

6698019-3 | Chills, Hypotension, Influenza, Lung Consolidation, Productive Cough, Pyrexia, Renal Failure, Respiratory Failure
on Apr 15, 2010 Male patient from UNITED STATES , 56 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: chills, hypotension, influenza, lung consolidation, productive cough, pyrexia, renal failure, respiratory failure. Thalomid dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ZOLEDRONIC ACID (View Zoledronic Acid Review and Zoledronic Acid Label ). Patient was hospitalized.

6693609-6 | Bronchitis, Candidiasis, Deep Vein Thrombosis, Dehydration, Gastritis, Hyperkalaemia, Multiple Myeloma, Oesophageal Stenosis
Patient was taking Thalomid (View Usage). Patient had the following side effects: bronchitis (What is bronchitis?), candidiasis, deep vein thrombosis (What is deep vein thrombosis?), dehydration, gastritis, hyperkalaemia, multiple myeloma (What is multiple myeloma?), oesophageal stenosis on Apr 12, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 150.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Thalomid dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), VELCADE (View Velcade Review and Velcade Label ), MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), PREVACID (View Prevacid Review and Prevacid Label ), PERCOCET (1-2 Tablets) (View Percocet Review and Percocet Label ). Patient was hospitalized.

6685740-6 | Pancreatic Carcinoma
Adverse event was reported on Apr 09, 2010 by a Female patient taking Thalomid (View Usage) (Dosage: ) . Location: UNITED STATES , 83 years of age, weighting 99.21 lb, After Thalomid was administered, patient had the following side effects: pancreatic carcinoma. During the same period patient was treated with MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6684890-8 | Bradycardia, Constipation, Deep Vein Thrombosis, Infection, Intestinal Infarction, Neuropathy Peripheral, Rash, Sedation
on Apr 07, 2010 Female patient from ITALY , 55 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, constipation (What is constipation?), deep vein thrombosis (What is deep vein thrombosis?), infection (What is infection?), intestinal infarction, neuropathy peripheral, rash (What is rash?), sedation. Thalomid dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6680760-X | Cough, Disease Progression, Fatigue, Oesophageal Rupture, Pregnancy, Treatment Noncompliance, Vomiting
on Apr 09, 2010 Female patient from UNITED STATES , weighting 123.1 lb, was treated with Thalomid (View Usage). Patient had the following side effects: cough, disease progression, fatigue, oesophageal rupture, pregnancy (What is pregnancy?), treatment noncompliance, vomiting. Thalomid dosage: . During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ).

6674291-0 | Myelofibrosis, Neoplasm Progression, Renal Failure Acute
Patient was taking Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: myelofibrosis, neoplasm progression, renal failure acute on Apr 05, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 195.2 lb, was diagnosed with myelofibrosis and. Thalomid dosage: . During the same period patient was treated with PROCRIT (View Procrit Review and Procrit Label ), HYDREA (View Hydrea Review and Hydrea Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ).

6673527-X | Atrial Thrombosis, Cardiac Arrest, Cardiomyopathy, Myeloma Recurrence, Venous Thrombosis
Adverse event was reported on Dec 22, 2008 by a Female patient taking Thalomid (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , 50 years of age, Patient experienced the following unwanted or unexpected effects: atrial thrombosis, cardiac arrest (What is cardiac arrest?), cardiomyopathy (What is cardiomyopathy?), myeloma recurrence, venous thrombosis. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6648056-X | Haemoglobin Decreased, Myelodysplastic Syndrome, Neutrophil Count Decreased
on Mar 10, 2010 Male patient from UNITED STATES , 89 years of age, weighting 163.1 lb, was treated with Thalomid (View Usage). Patient had the following side effects: haemoglobin decreased, myelodysplastic syndrome, neutrophil count decreased. Thalomid dosage: . During the same period patient was treated with MELPHALAN HYDROCHLORIDE (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), NIACIN (View Niacin Review and Niacin Label ), SENOKOT (View Senokot Review and Senokot Label ).

6644814-6 | Ileus, Jaundice
on Mar 08, 2010 Female patient from UNITED STATES , weighting 142.6 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: ileus, jaundice (What is jaundice?). Thalomid dosage: . During the same period patient was treated with PERCOCET (View Percocet Review and Percocet Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), COMPAZINE (View Compazine Review and Compazine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), BORTEZOMIB (View Bortezomib Review and Bortezomib Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), ZOLEDRONIC ACID (View Zoledronic Acid Review and Zoledronic Acid Label ), ERYTHROPOIETIC AGENT (View Erythropoietic Agent Review and Erythropoietic Agent Label ).

6641791-9 | Cough, Disease Progression, Fatigue, Oesophageal Rupture, Pregnancy, Treatment Noncompliance, Vomiting
Patient was taking Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: cough, disease progression, fatigue, oesophageal rupture, pregnancy (What is pregnancy?), treatment noncompliance, vomiting on Mar 05, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 123.1 lb, . Thalomid dosage: . During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ).

6637018-4 | Cerebrovascular Accident, Deep Vein Thrombosis, Hypereosinophilic Syndrome, Myocardial Infarction, Pericarditis, Pulmonary Embolism
Adverse event was reported on Mar 02, 2010 by a Female patient taking Thalomid (View Usage) (Dosage: ) . Location: FRANCE , 62 years of age, Patient had the following side effects: cerebrovascular accident, deep vein thrombosis (What is deep vein thrombosis?), hypereosinophilic syndrome, myocardial infarction, pericarditis, pulmonary embolism (What is pulmonary embolism?). Patient was hospitalized.

6629539-5 | Colorectal Cancer, Septic Shock
on Mar 01, 2010 Female patient from SPAIN , 60 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). After Thalomid was administered, patient had the following side effects: colorectal cancer (What is colorectal cancer?), septic shock. Thalomid dosage: .

6622314-7 | Colorectal Cancer, Septic Shock
on Mar 04, 2010 Female patient from SPAIN , 60 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Thalomid (View Usage). Patient experienced the following unwanted or unexpected effects: colorectal cancer (What is colorectal cancer?), septic shock. Thalomid dosage: .

6618544-0 | Cough, Disease Progression, Fatigue, Oesophageal Rupture, Pregnancy, Treatment Noncompliance, Vomiting
Patient was taking Thalomid (View Usage). Patient had the following side effects: cough, disease progression, fatigue, oesophageal rupture, pregnancy (What is pregnancy?), treatment noncompliance, vomiting on Feb 22, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 123.1 lb, . Thalomid dosage: . During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ).